###
中国临床研究:2019,32(12):1675-1677
本文二维码信息
码上扫一扫!
骨髓涂片联合免疫分型在早期诊断淋巴瘤白血病骨髓侵犯中的价值
(陕西省核工业215医院血液科,陕西 咸阳712000)
Value of bone marrow smear combined with immunotyping in early diagnosis of bone marrow involvement in lymphoma leukemia
(Department of Hematology,No.215 Hospital of Shaanxi Nuclear Industry,Xianyang,Shaanxi 712000,China)
摘要
本文已被:浏览 758次   下载 471
投稿时间:2019-05-15   网络发布日期:2019-12-23
中文摘要: 目的 分析骨髓涂片联合免疫分型在早期诊断淋巴瘤细胞白血病(LMCL)骨髓侵犯中的价值。方法 采用回顾性研究,收集本院2014年1月至2018年9月血液内科80例LMCL患者的临床资料,观察患者骨髓涂片形态学特点,并进行骨髓免疫分型分析,进一步分析骨髓涂片联合免疫分型在早期诊断LMCL骨髓侵犯中的价值。结果 80例患者骨髓中均存在典型的淋巴瘤细胞形态,免疫分型中分化抗原表达与原疾病病理类型相符,其中NK/T细胞型7例,占8.75%,B淋巴细胞型44例,占55.00%,T淋巴细胞型29例,占36.25%。本组NK/T细胞型的例数较少,其总共表达CD7、CD56、CD38、CD161、CD94、CD15;B细胞型LMCL患者主要表达skappa、CD79a、CD22、CD19、CD20和早期抗原HLA-DR等,其中CD19阳性率最高,占88.94%;T细胞型LMCL患者主要表达CD2、CD3、CD11b、CD7、CD5、CD34和HLA-DR,其中CD7最为敏感,其阳性率为68.97%。80例患者中,骨髓涂片与免疫分型中淋巴瘤细胞比例相符65例,占81.25%。结论 骨髓涂片联合免疫分型在早期诊断LMCL骨髓侵犯中具有一定的评估价值,二者可优势互补、取长补短、相互补充,有助于LMCL的早期诊断。
Abstract:ObjectiveTo analyze the value of bone marrow smear combined with immunotyping in early diagnosis of bone marrow involvement in lymphoma cell leukemia (LMCL). Methods The clinical data of 80 patients with LMCL were studied retrospectively.The morphological characteristics of bone marrow smear and the bone marrow immunotyping were observed to analyze the value of bone marrow smear combined with immunotyping in the early diagnosis of LMCL bone marrow involvement furtherly. Results Typical lymphoma cells were found in bone marrow of 80 patients.The differentiation antigen expression in immunophenotyping was consistent with the pathological type of the original disease,including NK/T cell type in 7 cases (8.75%),B lymphocyte type in 44 cases (55.00%) and T lymphocyte type in 29 cases (36.25%).In fewer cases of NK/T cell type,there were the expressions of CD7,CD56,CD38,CD161,CD94 and CD15.In B-cell type LMCL patients,there were the expressions of Skappa,CD79a,CD22,CD19,CD20 and early antigen HLA-DR,with the highest positive rate of CD19 (88.94%).CD2,CD3,CD11b,CD7,CD5,CD34 and HLA-DR were mainly expressed in T-cell type LMCL patients,in which CD7 was the most sensitive,with the positive rate of 68.97%.The proportion of lymphoma cells in bone marrow smear was consistent with that in immunotyping in 65 cases (81.25%). ConclusionIn early diagnosis of LMCL bone marrow involvement.Both bone marrow smear and immunotyping have certain value and can complement each other for the early diagnosis of LMCL.
文章编号:     中图分类号:R 733.7    文献标志码:B
基金项目:陕西省科技计划项目(2014K15-02-39)
引用文本:
滕志,许世娟.骨髓涂片联合免疫分型在早期诊断淋巴瘤白血病骨髓侵犯中的价值[J].中国临床研究,2019,32(12):1675-1677.

用微信扫一扫

用微信扫一扫